GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech
The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on…
The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on…
A new wave of therapies based on a unique type of immune cells, called gamma…
Abingworth has closed $315M (€268M) for its most recent fund, Abingworth Bioventures VII, which invests in…
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
Officially opened less than a year ago, The Francis Crick Institute is already conducting top-level…
Paolo Paoletti might have been forced to reconsider his career as a professor in medicine,…
GammaDelta Therapeutics and Takeda have formed a strategic collaboration to develop a novel T cell…
Just when we thought it couldn't become any more intense, the field of immuno-oncology is…